LHC Group (LHCG) Stock Rating Reaffirmed by Oppenheimer

LHC Group (NASDAQ:LHCG)‘s stock had its “buy” rating reissued by equities research analysts at Oppenheimer in a research report issued on Thursday. They currently have a $85.00 price target on the health services provider’s stock. Oppenheimer’s target price indicates a potential upside of 33.02% from the company’s current price.

Several other research analysts also recently issued reports on LHCG. Robert W. Baird set a $71.00 price target on shares of LHC Group and gave the stock a “hold” rating in a research report on Tuesday, November 28th. Bank of America began coverage on shares of LHC Group in a research report on Monday, August 21st. They set a “buy” rating and a $76.00 price target on the stock. ValuEngine downgraded shares of LHC Group from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. BidaskClub upgraded shares of LHC Group from a “hold” rating to a “buy” rating in a research report on Friday, August 18th. Finally, Royal Bank Of Canada restated a “buy” rating and set a $70.00 target price on shares of LHC Group in a research report on Wednesday, September 6th. Three investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $77.10.

Shares of LHC Group (NASDAQ:LHCG) traded up $0.94 during midday trading on Thursday, reaching $63.90. 278,800 shares of the company traded hands, compared to its average volume of 148,111. The firm has a market cap of $1,150.85, a P/E ratio of 27.02, a price-to-earnings-growth ratio of 1.87 and a beta of 0.69. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.24. LHC Group has a 1-year low of $41.66 and a 1-year high of $76.14.

LHC Group (NASDAQ:LHCG) last issued its quarterly earnings results on Monday, November 6th. The health services provider reported $0.64 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.60 by $0.04. The business had revenue of $272.90 million for the quarter, compared to the consensus estimate of $265.35 million. LHC Group had a net margin of 4.09% and a return on equity of 9.52%. The firm’s quarterly revenue was up 18.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.54 EPS. research analysts predict that LHC Group will post 2.4 earnings per share for the current year.

In other LHC Group news, COO Donald Dwayne Stelly sold 2,650 shares of the company’s stock in a transaction dated Friday, September 8th. The shares were sold at an average price of $65.34, for a total transaction of $173,151.00. Following the transaction, the chief operating officer now directly owns 109,235 shares in the company, valued at approximately $7,137,414.90. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 14.80% of the company’s stock.

Large investors have recently made changes to their positions in the stock. Federated Investors Inc. PA raised its position in shares of LHC Group by 4.2% in the 2nd quarter. Federated Investors Inc. PA now owns 1,622 shares of the health services provider’s stock valued at $110,000 after acquiring an additional 66 shares during the period. Acrospire Investment Management LLC raised its position in shares of LHC Group by 30.8% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,700 shares of the health services provider’s stock valued at $115,000 after acquiring an additional 400 shares during the period. Cubist Systematic Strategies LLC raised its position in shares of LHC Group by 758.0% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 1,716 shares of the health services provider’s stock valued at $116,000 after acquiring an additional 1,516 shares during the period. First Mercantile Trust Co. acquired a new stake in shares of LHC Group in the 2nd quarter valued at approximately $147,000. Finally, SG Americas Securities LLC acquired a new stake in shares of LHC Group in the 3rd quarter valued at approximately $163,000. Institutional investors and hedge funds own 85.51% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece of content was first posted by Stock Observer and is owned by of Stock Observer. If you are accessing this piece of content on another website, it was illegally stolen and reposted in violation of United States & international copyright law. The correct version of this piece of content can be read at https://www.thestockobserver.com/2017/12/07/lhc-group-lhcg-stock-rating-reaffirmed-by-oppenheimer.html.

About LHC Group

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply